Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03678441 · ClinicalTrials.gov registry record · NA
Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery
A NA study of Liver and Intrahepatic Bile Duct Disorder, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03678441 is a NA study of Liver and Intrahepatic Bile Duct Disorder that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03678441, a NA study of Liver and Intrahepatic Bile Duct Disorder, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well electronic neurocognitive tools work in screening for mental capability in patients who are undergoing liver surgery. Using electronic neurocognitive screening tools may help to better assess mental impairment.
Conditions Studied
Interventions
- PROCEDURE Cognitive Assessment
- BEHAVIORAL BrainCheck Cognitive Assessment
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-08-17 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03678441
The ClinicalTrials.gov registry entry for NCT03678441 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver and Intrahepatic Bile Duct Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Assessment is the first listed.
NCT03678441 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03678441 about?
NCT03678441 is a clinical study titled "Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery". This trial studies how well electronic neurocognitive tools work in screening for mental capability in patients who are undergoing liver surgery. Using electronic neurocognitive screening tools may help to better assess mental impairment.
What is the current status of trial NCT03678441?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2018-08-17. Estimated completion is 2027-04-30.
What conditions does trial NCT03678441 study?
This clinical trial studies the following conditions: Liver and Intrahepatic Bile Duct Disorder.
What interventions are being tested in trial NCT03678441?
The interventions under investigation include: Cognitive Assessment (PROCEDURE), BrainCheck Cognitive Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03678441?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03678441 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver and Intrahepatic Bile Duct Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.